1. Home
  2. BTMD vs XTNT Comparison

BTMD vs XTNT Comparison

Compare BTMD & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biote Corp.

BTMD

Biote Corp.

N/A

Current Price

$2.00

Market Cap

72.7M

Sector

Health Care

ML Signal

N/A

Logo Xtant Medical Holdings Inc.

XTNT

Xtant Medical Holdings Inc.

N/A

Current Price

$0.47

Market Cap

68.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BTMD
XTNT
Founded
2012
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
72.7M
68.9M
IPO Year
2021
2009

Fundamental Metrics

Financial Performance
Metric
BTMD
XTNT
Price
$2.00
$0.47
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
1
Target Price
$2.83
$1.00
AVG Volume (30 Days)
216.3K
147.8K
Earning Date
05-06-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
722.22
125.00
EPS
0.06
N/A
Revenue
$192,219,000.00
$53,337,000.00
Revenue This Year
$2.03
N/A
Revenue Next Year
$6.58
$9.30
P/E Ratio
$33.58
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.27
$0.44
52 Week High
$4.75
$0.95

Technical Indicators

Market Signals
Indicator
BTMD
XTNT
Relative Strength Index (RSI) 48.34 41.83
Support Level $1.97 $0.44
Resistance Level $2.17 $0.67
Average True Range (ATR) 0.14 0.03
MACD -0.02 -0.00
Stochastic Oscillator 37.58 28.18

Price Performance

Historical Comparison
BTMD
XTNT

About BTMD Biote Corp.

Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.

About XTNT Xtant Medical Holdings Inc.

Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.

Share on Social Networks: